Pfam Domains GO Terms
| CARD |
| Peptidase C14 |
| apoptosome |
| glial cell apoptotic process |
| activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c |
| cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| response to cobalt ion |
| cysteine-type endopeptidase activity involved in apoptotic process |
| platelet formation |
| platelet morphogenesis |
| leukocyte apoptotic process |
| cellular response to dexamethasone stimulus |
| extrinsic apoptotic signaling pathway in absence of ligand |
| signal transduction in absence of ligand |
| response to dexamethasone |
| enzyme activator activity |
| response to ischemia |
| positive regulation of neuron apoptotic process |
| cellular response to glucocorticoid stimulus |
| cellular response to corticosteroid stimulus |
| intrinsic apoptotic signaling pathway in response to DNA damage |
| peptidase activity |
| cellular response to UV |
| activation of cysteine-type endopeptidase activity involved in apoptotic process |
| cellular response to ketone |
| cysteine-type endopeptidase activity |
| positive regulation of neuron death |
| response to antineoplastic agent |
| extrinsic apoptotic signaling pathway |
| signal transduction in response to DNA damage |
| cellular response to light stimulus |
| SH3 domain binding |
| positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| response to estradiol |
| response to UV |
| response to glucocorticoid |
| intrinsic apoptotic signaling pathway |
| positive regulation of cysteine-type endopeptidase activity |
| response to corticosteroid |
| positive regulation of endopeptidase activity |
| cellular response to radiation |
| cellular response to xenobiotic stimulus |
| cellular response to steroid hormone stimulus |
| positive regulation of peptidase activity |
| response to ketone |
| regulation of neuron apoptotic process |
| regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| regulation of response to DNA damage stimulus |
| myeloid cell differentiation |
| regulation of cysteine-type endopeptidase activity |
| kidney development |
| aging |
| apoptotic signaling pathway |
| renal system development |
| response to xenobiotic stimulus |
| response to antibiotic |
| response to light stimulus |
| regulation of neuron death |
| response to lipopolysaccharide |
| cellular response to environmental stimulus |
| cellular response to abiotic stimulus |
| urogenital system development |
| response to molecule of bacterial origin |
| response to steroid hormone |
| positive regulation of proteolysis |
| response to metal ion |
| cellular response to drug |
| regulation of endopeptidase activity |
| response to radiation |
| regulation of peptidase activity |
| protein kinase binding |
| cellular response to lipid |
| response to inorganic substance |
| cellular response to organic cyclic compound |
| cell morphogenesis involved in differentiation |
| hemopoiesis |
| protein-containing complex |
| cellular response to hormone stimulus |
| hematopoietic or lymphoid organ development |
| positive regulation of apoptotic process |
| immune system development |
| positive regulation of programmed cell death |
| response to bacterium |
| positive regulation of cell death |
| cell morphogenesis |
| regulation of proteolysis |
| regulation of cellular response to stress |
| positive regulation of hydrolase activity |
| cellular response to DNA damage stimulus |
| cellular component morphogenesis |
| response to lipid |
| anatomical structure formation involved in morphogenesis |
| response to hormone |
| response to organic cyclic compound |
| apoptotic process |
| response to drug |
| programmed cell death |
| cellular response to oxygen-containing compound |
| cell death |
| response to abiotic stimulus |
| cellular response to endogenous stimulus |
| mitochondrion |
| proteolysis |
| regulation of hydrolase activity |
| response to other organism |
| response to external biotic stimulus |
| response to biotic stimulus |
| positive regulation of catalytic activity |
| response to endogenous stimulus |
| regulation of response to stress |
| regulation of apoptotic process |
| response to oxygen-containing compound |
| regulation of programmed cell death |
| positive regulation of cellular protein metabolic process |
| cell development |
| regulation of cell death |
| intracellular signal transduction |
| cellular response to stress |
| positive regulation of protein metabolic process |
| positive regulation of molecular function |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Gene | Correlation |
|---|---|
| BAK1 | 0.799 |
| APAF1 | 0.79 |
| HCCS | 0.752 |
| MARCH5 | 0.751 |
| CYCS | 0.728 |
| VDAC2 | 0.722 |
| PLAA | 0.718 |
| UBQLN1 | 0.712 |
| DIABLO | 0.661 |
| DOHH | 0.656 |
| SERF2 | 0.629 |
| HSPD1 | 0.627 |
| TRIAP1 | 0.596 |
| ENY2 | 0.593 |
| FAF2 | 0.591 |
| THG1L | 0.589 |
| BAP1 | 0.581 |
| RPTOR | 0.57 |
| METAP2 | 0.561 |
| GFPT1 | 0.557 |
| UAP1 | 0.552 |
| ROMO1 | 0.55 |
| MFN1 | 0.537 |
| ATP5J | 0.533 |
| RAD23B | 0.531 |
| GMPPB | 0.526 |
| CSNK2B | 0.525 |
| ATAD1 | 0.524 |
| STAU1 | 0.518 |
| MEAF6 | 0.517 |
| RNMT | 0.517 |
| GABPA | 0.516 |
| HARS | 0.514 |
| UBE2K | 0.513 |
| NXT1 | 0.503 |
| PMM2 | 0.5 |
| PPA2 | 0.5 |
| NSD1 | 0.498 |
| MTOR | 0.495 |
| DPAGT1 | 0.494 |
| ZZZ3 | 0.489 |
| CRLS1 | 0.488 |
| OPA1 | 0.485 |
| ALG1 | 0.481 |
| RTCB | 0.478 |
| DHPS | 0.477 |
| WDR24 | 0.476 |
| SLC25A26 | 0.475 |
| TAZ | 0.474 |
| TIMM13 | 0.473 |
| ATP5B | 0.469 |
| ATP5I | 0.467 |
| ALG2 | 0.465 |
| PPP2R3C | 0.464 |
| ATP5O | 0.464 |
| MLST8 | 0.463 |
| WDR59 | 0.463 |
| UBE2G2 | 0.461 |
| NUPL2 | 0.455 |
| RPN1 | 0.453 |
| ATP5A1 | 0.452 |
| EXOC4 | 0.452 |
| KDSR | 0.45 |
| FBXO11 | 0.448 |
| PAM16 | 0.448 |
| SRP14 | 0.447 |
| CBFB | 0.445 |
| PDPK1 | 0.445 |
| TAMM41 | 0.444 |
| ORAOV1 | 0.444 |
| THOC6 | 0.443 |
| KCTD5 | 0.442 |
| NAE1 | 0.441 |
| VHL | 0.441 |
| ADSL | 0.44 |
| DDHD2 | 0.439 |
| RPE | 0.439 |
| FECH | 0.435 |
| ABCF1 | 0.435 |
| SRRD | 0.434 |
| UBA3 | 0.432 |
| TRIM28 | 0.429 |
| ELP3 | 0.427 |
| CTDNEP1 | 0.426 |
| ATXN10 | 0.424 |
| CARS | 0.422 |
| DR1 | 0.419 |
| PRKRIR | 0.418 |
| SUPV3L1 | 0.416 |
| SSB | 0.415 |
| ALG5 | 0.415 |
| LAMTOR4 | 0.415 |
| DAD1 | 0.414 |
| SEC61G | 0.412 |
| ATP5D | 0.41 |
| PELO | 0.409 |
| TBP | 0.408 |
| OIP5 | 0.407 |
| VEZT | 0.406 |
| ATP5F1 | 0.406 |
| MAPKAP1 | 0.405 |
| SEC16A | 0.405 |
| LAMTOR5 | 0.404 |
| PIK3R4 | 0.401 |
| TRNT1 | 0.401 |
| VRK1 | 0.401 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution